Symphogen A/S
Records under this name other than the patents Symphogen A/S holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,414,896 | Recombinant anti-epidermal growth factor receptor antibody compositions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,887,805 | Recombinant anti-epidermal growth factor receptor antibody compositions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,283,294 | Method for cloning cognate antibodies Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,663,640 | Methods using recombinant anti-epidermal growth factor receptor antibody compositions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,450,376 | Anti-MET antibodies and compositions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,034,765 | ANTI-PD-1 Antibodies and Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 11,834,503 | ANTI-LAG-3 Antibodies and Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 11,359,018 | Anti-PD-1 Antibodies and Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 12,030,942 | Anti-PD-1 antibodies and compositions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,390,674 | ANTI-TIM-3 Antibodies and Compositions Formerly held In force · High confidence | In force | High confidence |